Predictable Timelines. Precision Toxicology.

 Proven Quality.

Chemical characterisation is no longer a check box exercise. For today’s medical device developers, extractables and leachables (E&L) testing plays a critical role in risk mitigation, regulatory submission, and avoiding costly setbacks later in development. But for many small to mid-sized manufacturers, this stage is riddled with uncertainty. What testing do I really need?

The Eurofins Medical Device Services network of laboratories provides the clarity, speed, and scientific expertise you need to move forward with confidence. Our ISO 17025-accredited facilities, staffed by 100 dedicated E&L scientists, offer more than 30 years of experience and access to more than 500 advanced HPLC and GC systems. 

Important phases in your product development lifecycle that may require E&L assessments include:

  • Developing new product design concepts 
  • Performing verification testing for your design history file  
  • Changing raw material suppliers 
  • Implementing design or manufacturing process changes 

From protocol design to toxicological risk assessment, we support you every step of the way. We will work with you to:

  • Determine the most appropriate test conditions for your device 
  • Select the right solvents and extraction methods 
  • Perform exhaustive or exaggerated extractables studies (ISO 10993-18) 
  • Conduct simulated-use or leachables testing based on real-world exposure 
  • Identify compounds using our proprietary spectral database of more than 1,500 non-volatile substances 
  • Perform toxicological risk assessments (ISO 10993-17) with reports ready for regulatory submission 

Our coordinated E&L packages, often delivered in parallel with biocompatibility testing,  compress timelines and reduce the risk of late-stage issues. With direct access to our expert toxicologists, your project will benefit from real-time troubleshooting, guided decisions, and clear justifications for regulatory authorities.

  • One unified workflow for E&L, toxicology, and biocompatibility 
  • Dedicated project manager and expert point of contact 
  • Risk assessments aligned with FDA guidance and ISO 10993 standards 
  • Support during changes to raw materials, suppliers, or manufacturing processes 

Whether you're launching a new product, submitting a 510(k), or responding to a regulatory query, our goal is to help you uncover any potential issues before they become costly complications.

The responsive, reliable, and accessible teams within Eurofins Medical Device Services  ensure your E&L project stays on track, on time, and on budget. 

Instrumentation

Agilent LC/MS TOF and QTOF

Agilent/Waters HPLC/UHPLC – including UV/Vis, RI, Fluorescence, ELSD, CAD, and Conductivity detectors

Agilent GC/MS – both headspace and direct injection sample introduction

Agilent GC/FID/TCD – both headspace and direct injection sample introduction

Agilent ICP/MS and ICP/OES

Thermo Scientific iCAP ICP-OES

Thermo Scientific LC/MS/MS

Perkin Elmer ICP-OES

Perkin Elmer 350 ATD Thermal Desorber

Bruker Avance 3 (500 MHz) Liquid NMR

Bruker Avance 3 (400 MHz) Liquid NMR

Available Tests

Our extractables studies can be designed according to guidance such as ISO 10993 Part 18, USP <1663> and <1664>, as well as FDA/CDRH, EMEA and PQRI documents.

Validation in compliance with ISO 10993-18

Extraction Techniques (for exaggerated, exhaustive, and simulated-use extraction)

Reflux 
Soxhlet 
Sonication 
Incubation/maceration in controlled temperature conditions (with agitation if needed) 

Analysis Techniques

Fingerprinting by GC-FID/MS 
Semi-quantitative screening for both volatile and semi-volatile organic compounds by GC/MS and GC/MS Headspace 
Semi-quantitative screening for non-volatile organic compounds by LC/MS 
Quantitative analysis for metals by ICP/OES or ICP/MS 
Gravimetric (NVR) determination of extractables 
FTIR 
TOC Analysis 
pH 
Conductivity

Method establishment for novel extraction matrices

Toxicological risk assessment

Additional Complementary Services

Method Development & Validation

Stability for Leachables

Toxicological Risk Assessments

Biocompatibility Testing

Biological Evaluation Plans